Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ASTH	ASTRANA HEALTH INC	$1.40B	1.30%	0.60%	4.39%	9.60%	2.17	1.40	10.30%	0.30%	2.43%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$22.42M	-219.00%	-178.10%	-82.92%	-1,205.80%	0.11	10.42	N/A	N/A	N/A
AQST	AQUESTIVE THERAPEUTICS INC	$788.14M	N/A	-59.90%	-37.64%	-38.10%	-40.81	5.93	60.30%	-158.90%	-119.69%
BKD	BROOKDALE SENIOR LIVING INC	$2.56B	-267.90%	-5.00%	-1.07%	-0.50%	-894.08	0.84	19.80%	-9.50%	-1.79%
CGC	CANOPY GROWTH CORP	$390.10M	-67.00%	-38.00%	-38.91%	-41.30%	0.45	5.50	26.80%	-138.50%	-138.08%
LITS	LITE STRATEGY INC	$48.56M	-27.10%	-26.20%	-10.31%	-47.00%	0.01	12.39	N/A	N/A	N/A
MIST	MILESTONE PHARMACEUTICALS INC	$172.04M	-2,372.70%	-85.10%	-70.24%	-73.30%	3.28	8.24	N/A	N/A	N/A
PTGX	PROTAGONIST THERAPEUTICS INC	$5.46B	6.90%	6.30%	7.32%	8.50%	0.09	13.05	100.00%	21.90%	22.98%
ADCT	ADC THERAPEUTICS SA	$437.29M	N/A	-55.40%	-50.64%	-97.80%	-2.22	4.63	92.70%	-222.00%	-153.31%
COGT	COGENT BIOSCIENCES INC	$5.06B	-126.20%	-89.70%	-80.45%	-153.00%	0.41	6.38	N/A	N/A	N/A
MXCT	MAXCYTE INC	$165.34M	-23.50%	-20.20%	-23.12%	-22.10%	0.18	7.74	80.00%	-132.60%	-132.58%
CVM	CEL SCI CORP	$44.23M	-240.40%	-105.90%	-107.54%	-115.00%	0.76	2.26	N/A	N/A	N/A
ECOR	ELECTROCORE INC	$35.86M	-474.00%	-78.10%	-150.68%	-148.50%	-20.96	1.43	86.00%	-47.50%	-46.82%
TERN	TERNS PHARMACEUTICALS INC	$3.64B	-30.00%	-28.50%	-32.91%	-55.60%	0.06	19.52	N/A	N/A	N/A
WOK	WORK MEDICAL TECHNOLOGY GROUP LTD	$3.18k	-32.00%	-11.00%	-21.30%	-13.70%	1.47	1.14	26.90%	-34.50%	-31.20%
GPCR	STRUCTURE THERAPEUTICS INC	$4.22B	-26.10%	-24.70%	-27.14%	-31.10%	0.08	14.15	N/A	N/A	N/A
HYPD	HYPERION DEFI INC	$28.83M	-123.80%	-71.30%	-30.02%	-78.70%	0.17	2.25	-798.10%	-7,643.90%	-6,846.13%
PMI	PICARD MEDICAL INC	$128.98M	N/A	N/A	N/A	N/A	0.70	2.16	N/A	N/A	N/A
OM	OUTSET MEDICAL INC	$67.35M	-71.10%	-30.70%	-29.54%	-23.70%	0.95	7.09	37.70%	-73.10%	-59.00%
RAPP	RAPPORT THERAPEUTICS INC	$1.45B	-28.60%	-27.20%	-18.75%	-38.90%	0.05	36.37	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$709.84M	-49.00%	-44.70%	-36.20%	-139.20%	0.13	9.01	N/A	N/A	N/A
IRD	OPUS GENETICS INC	$138.62M	-774.20%	-170.70%	-968.51%	467.50%	5.05	1.24	100.00%	-466.10%	-465.63%
CTNM	CONTINEUM THERAPEUTICS INC	$333.56M	-32.30%	-30.30%	-32.19%	-35.60%	0.06	29.07	N/A	N/A	N/A
NKTX	NKARTA INC	$131.40M	-27.70%	-22.20%	-25.13%	-21.80%	0.26	15.24	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$291.08M	-1,042.80%	-565.50%	-891.35%	1,235.40%	0.74	2.35	N/A	N/A	N/A
BBNX	BETA BIONICS INC	$1.34B	-46.80%	-27.10%	-25.55%	-32.90%	0.12	10.64	54.50%	-87.90%	-87.89%
ACON	ACLARION INC	$3.09M	-68.00%	-63.50%	-58.67%	2,444.20%	0.06	17.01	-7.80%	-10,948.20%	-10,867.45%
TNDM	TANDEM DIABETES CARE INC	$1.49B	-118.80%	-22.30%	-31.71%	-18.80%	5.58	2.44	53.20%	-20.20%	-19.59%
PROK	PROKIDNEY CORP	$673.87M	N/A	-18.10%	-20.87%	-24.90%	-0.03	10.32	100.00%	-9,547.40%	-9,049.33%
SSII	SS INNOVATIONS INTERNATIONAL INC	$1.10B	-50.40%	-27.90%	-29.04%	-34.60%	0.76	2.29	48.30%	-51.00%	-41.86%
VERU	VERU INC	$34.35M	-111.70%	-70.10%	-103.06%	-786.10%	0.63	2.43	N/A	N/A	N/A
NRXP	NRX PHARMACEUTICALS INC	$76.14M	N/A	-489.90%	148.69%	172.10%	-1.58	0.29	59.90%	-15,727.70%	-15,727.69%
LTRN	LANTERN PHARMA INC	$33.89M	-126.00%	-97.40%	-197.36%	-232.80%	0.42	3.33	N/A	N/A	N/A
QNTM	QUANTUM BIOPHARMA LTD	$27.86M	-384.90%	-185.60%	-370.55%	-12,582.70%	0.77	1.41	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$12.74M	-310.90%	-125.10%	-261.69%	-289.60%	1.70	2.30	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$2.54B	-31.20%	-26.80%	-32.51%	-35.40%	0.11	10.91	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$134.61M	15.30%	3.60%	4.46%	3.60%	2.28	2.30	100.00%	1,536.80%	1,536.75%
ACRV	ACRIVON THERAPEUTICS INC	$76.05M	-53.70%	-48.30%	-62.69%	-69.00%	0.13	8.75	N/A	N/A	N/A
SVRA	SAVARA INC	$1.23B	-86.60%	-65.40%	-93.14%	-66.40%	0.49	7.65	N/A	N/A	N/A
ABOS	ACUMEN PHARMACEUTICALS INC	$127.81M	-97.40%	-70.40%	-107.41%	-81.60%	0.53	6.02	N/A	N/A	N/A
ESLA	ESTRELLA IMMUNOPHARMA INC	$58.91M	N/A	-446.70%	137.24%	246.60%	-1.36	0.15	N/A	N/A	N/A
PHVS	PHARVARIS NV	$1.80B	-66.20%	-60.20%	N/A	-1,563.70%	0.09	N/A	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$436.37M	-25.70%	-24.80%	-13.73%	-155.60%	0.02	56.10	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$74.97M	-71.50%	-53.30%	-66.51%	-62.10%	0.38	13.94	N/A	N/A	N/A
THAR	THARIMMUNE INC	$106.19M	-588.40%	-264.40%	-167.25%	641.10%	0.25	4.99	N/A	N/A	N/A
SY	SO-YOUNG INTERNATIONAL INC	$255.07M	-42.20%	-27.80%	-37.41%	-67.70%	0.51	2.20	51.60%	-51.80%	-51.50%
KYTX	KYVERNA THERAPEUTICS INC	$411.68M	-77.90%	-65.80%	-104.98%	-103.60%	0.23	5.16	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$1.83B	-160.60%	-49.60%	-64.57%	-38.50%	3.78	4.64	95.40%	-279.30%	-253.32%
OMER	OMEROS CORP	$1.22B	N/A	-53.90%	-121.65%	-23.80%	-1.84	0.89	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$101.30M	N/A	-324.00%	233.91%	-991.70%	-1.58	0.38	4.00%	-4,416.20%	-4,505.98%
BIOA	BIOAGE LABS INC	$474.36M	-25.10%	-22.80%	-26.68%	-137.60%	0.10	11.87	100.00%	-1,280.90%	-1,265.29%
OVID	OVID THERAPEUTICS INC	$116.08M	-63.70%	-46.10%	-63.68%	-62.50%	0.43	4.24	100.00%	-549.60%	-549.62%
SANA	SANA BIOTECHNOLOGY INC	$1.08B	-120.60%	-53.80%	-58.61%	-127.50%	1.23	4.56	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$1.12B	-81.70%	-61.80%	-77.18%	-150.90%	0.29	4.47	100.00%	-36,145.10%	-35,938.25%
IMNM	IMMUNOME INC	$1.97B	-87.20%	-75.60%	-83.13%	-373.20%	0.13	8.90	100.00%	-2,301.30%	-2,301.30%
DYN	DYNE THERAPEUTICS INC	$2.79B	-66.20%	-56.30%	-52.13%	-146.40%	0.25	13.47	N/A	N/A	N/A
PTHS	PELTHOS THERAPEUTICS INC	$94.91M	-210.30%	-72.80%	-21.88%	-431.20%	1.17	2.01	68.70%	-318.40%	-300.30%
KLRS	KALARIS THERAPEUTICS INC	$157.85M	-76.00%	-52.30%	-66.92%	-1,029.20%	0.94	12.89	N/A	N/A	N/A
ACXP	ACURX PHARMACEUTICALS INC	$5.19M	-362.10%	-175.30%	-252.13%	359.90%	0.68	2.47	N/A	N/A	N/A
PALI	PALISADE BIO INC	$350.16M	-240.70%	-137.30%	-320.89%	577.10%	1.17	1.96	N/A	N/A	N/A
ALLO	ALLOGENE THERAPEUTICS INC	$307.88M	-57.80%	-43.10%	-51.66%	-53.00%	0.40	8.19	N/A	N/A	N/A
PCSA	PROCESSA PHARMACEUTICALS INC	$6.53M	-301.40%	-217.30%	-221.71%	250,955.20%	0.30	3.76	N/A	N/A	N/A
NRSN	NEUROSENSE THERAPEUTICS LTD	$18.92M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
QURE	UNIQURE NV	$1.49B	-373.70%	-35.70%	-20.62%	-22.70%	2.88	7.12	88.10%	-1,492.90%	-1,031.34%
SLRX	SALARIUS PHARMACEUTICALS INC	$3.80M	-401.00%	-155.80%	-117.81%	443.70%	0.44	3.28	N/A	N/A	N/A
RGNX	REGENXBIO INC	$728.97M	-78.30%	-34.50%	-33.89%	-26.00%	2.25	2.67	87.20%	-110.30%	-84.16%
ELTX	ELICIO THERAPEUTICS INC	$139.22M	-5,657.90%	-160.70%	-205.92%	-320.10%	6.41	3.30	N/A	N/A	N/A
RARE	ULTRAGENYX PHARMACEUTICAL INC	$2.22B	-436.00%	-43.70%	-67.82%	-38.30%	543.90	1.89	84.70%	-91.90%	-91.46%
ARMP	ARMATA PHARMACEUTICALS INC	$228.15M	N/A	-54.50%	63.18%	-29.50%	-1.94	0.12	100.00%	-3,797.70%	-2,580.16%
QTRX	QUANTERIX CORP	$297.08M	-30.50%	-23.60%	-27.57%	-38.70%	0.41	3.02	51.50%	-73.50%	-77.68%
MAZE	MAZE THERAPEUTICS INC	$1.99B	-65.20%	-31.20%	-31.61%	-208.60%	0.11	17.70	N/A	N/A	N/A
STIM	NEURONETICS INC	$94.51M	-151.30%	-31.60%	-31.45%	-27.20%	4.17	2.24	50.40%	-34.30%	-28.22%
GLPG	GALAPAGOS NV	$2.15B	-16.20%	-11.30%	-14.48%	-14.00%	0.44	8.63	71.10%	-151.40%	-158.11%
MOVE	MOVANO INC	$6.94M	-398.80%	-165.30%	1,135.50%	3,692.40%	-4.27	0.70	-270.20%	-3,409.60%	-3,109.00%
ABCL	ABCELLERA BIOLOGICS INC	$1.02B	-17.00%	-12.60%	-15.92%	-17.70%	0.41	10.10	100.00%	-486.00%	-580.13%
ELVN	ENLIVEN THERAPEUTICS INC	$913.95M	-24.90%	-24.00%	-20.41%	-34.80%	0.03	32.95	N/A	N/A	N/A
ALXO	ALX ONCOLOGY HOLDINGS INC	$61.27M	-138.90%	-96.70%	-193.39%	-132.10%	0.85	2.40	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$500.64M	-29.60%	-27.90%	-30.03%	-33.60%	0.09	12.69	100.00%	-336.50%	-333.61%
IMMX	IMMIX BIOPHARMA INC	$175.61M	-263.50%	-120.00%	-254.88%	547.00%	1.43	1.53	N/A	N/A	N/A
TVRD	TVARDI THERAPEUTICS INC	$40.34M	-115.90%	-33.70%	-31.65%	-30.90%	0.40	3.48	100.00%	-346.50%	-220.05%
CLOV	CLOVER HEALTH INVESTMENTS CORP	$1.21B	-17.10%	-10.10%	-15.93%	-31.80%	0.64	1.71	21.20%	-3.30%	-3.29%
FLGC	FLORA GROWTH CORP	$4.64M	-81.60%	-43.90%	-23.97%	-88.40%	0.14	2.08	17.50%	-32.10%	-31.54%
ARAY	ACCURAY INC	$93.51M	-32.10%	-4.10%	0.50%	0.40%	6.38	1.56	30.80%	-4.30%	0.29%
GNLX	GENELUX CORP	$165.91M	-129.30%	-97.40%	-160.49%	-169.50%	0.34	4.20	N/A	N/A	N/A
RPID	RAPID MICRO BIOSYSTEMS INC	$128.54M	-73.90%	-51.60%	-66.72%	-73.80%	0.90	4.23	7.70%	-145.10%	-148.33%
NTLA	INTELLIA THERAPEUTICS INC	$1.04B	-57.20%	-44.60%	-53.61%	-51.60%	0.24	6.21	100.00%	-774.90%	-774.94%
IMTX	IMMATICS NV	$1.28B	-23.30%	-19.10%	-26.21%	-40.90%	0.24	7.36	100.00%	-136.70%	-141.11%
IMMP	IMMUTEP LTD	$417.67M	-36.90%	-34.30%	-42.57%	-130.80%	0.09	11.69	100.00%	-594.60%	-594.28%
CRNX	CRINETICS PHARMACEUTICALS INC	$4.42B	-35.10%	-32.00%	-37.71%	-36.00%	0.12	15.12	100.00%	-27,563.30%	-27,563.32%
VNDA	VANDA PHARMACEUTICALS INC	$521.23M	-16.80%	-13.40%	-22.17%	-33.30%	0.29	3.12	94.40%	-39.70%	-50.52%
INKT	MINK THERAPEUTICS INC	$52.34M	N/A	-180.10%	-807.47%	238.30%	-2.11	1.08	N/A	N/A	N/A
TAOX	TAO SYNERGIES INC	$26.23M	-244.20%	-152.10%	-153.61%	-540.70%	0.11	17.61	100.00%	-13,058.70%	-12,829.93%
MRKR	MARKER THERAPEUTICS INC	$24.84M	-92.40%	-75.70%	-77.48%	3,325.10%	0.18	6.50	100.00%	-304.50%	-303.47%
LNAI	LUNAI BIOWORKS INC	$20.67M	-385.10%	-214.50%	1,021.63%	738.00%	-1.53	0.04	N/A	N/A	N/A
APLM	APOLLOMICS INC	$20.63M	-380.10%	-136.50%	-4,767.85%	1,243.90%	-3.53	0.97	100.00%	-366.90%	-362.92%
IOBT	IO BIOTECH INC	$43.82M	-465.40%	-180.60%	-407.32%	5,856.20%	42.86	2.01	N/A	N/A	N/A
ANIX	ANIXA BIOSCIENCES INC	$102.70M	-63.10%	-59.20%	-71.32%	-71.90%	0.14	8.45	N/A	N/A	N/A
FBRX	FORTE BIOSCIENCES INC	$341.61M	-75.60%	-65.90%	-61.53%	-3,473.20%	0.15	7.34	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$45.73M	-566.60%	-447.90%	-161.29%	2,487.30%	0.06	17.51	N/A	N/A	N/A
MIRA	MIRA PHARMACEUTICALS INC	$63.23M	-1,677.80%	-1,519.20%	-74.14%	-532.80%	0.01	90.53	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	615	+0.27%	-2.56%	+0.97%	-41.73%	146.65x	5.25x	-24.86%	-9.63%	-5.94%	+53.28%	Strong Buy
Diagnostics & Research	57	-0.98%	-1.53%	-3.92%	+15.95%	22.62x	4.43x	-1.14%	+6.19%	+13.13%	+8.73%	Buy
Drug Manufacturers - General	20	-0.36%	-0.64%	+0.75%	+29.59%	46.13x	6.93x	+106.72%	+12.28%	+20.38%	+4.48%	Buy
Drug Manufacturers - Specialty & Generic	77	-0.56%	-2.69%	+2.08%	-2.13%	-31.58x	2.36x	+9.51%	+2.96%	+5.96%	+55.56%	Strong Buy
Healthcare Plans	10	-0.12%	+1.21%	+5.01%	-15.66%	43.65x	2.07x	+12.19%	+3.78%	+9.23%	+14.08%	Buy
Health Information Services	54	-1.69%	-1.94%	-3.58%	-49.84%	42.11x	3.83x	+8.87%	+4.67%	+6.54%	+39.06%	Strong Buy
Medical Care Facilities	50	-1.25%	-1.53%	-4.54%	-42.75%	15.02x	5.23x	-80.60%	+7.33%	+16.04%	+20.06%	Buy
Medical Devices	139	+0.40%	-1.57%	-14.79%	-92.02%	23.79x	3.87x	+11.80%	+7.14%	+8.17%	+38.40%	Strong Buy
Medical Distribution	10	-0.79%	-0.70%	-3.80%	+44.38%	31.24x	3,562.64x	-56.46%	+3.41%	+21.83%	+9.05%	Buy
Medical Instruments & Supplies	57	-0.94%	-1.78%	+0.33%	-31.91%	222.67x	3.29x	+10.08%	+8.62%	+11.38%	+15.84%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 38, which is 12 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock lose -23.93% over the past year, overperforming other healthcare stocks by 39 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -10.98% from Ironwood Pharmaceuticals's current stock price of $3.37.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #2 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 63.03% over the past year, overperforming other healthcare stocks by 126 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -0.27% from Pediatrix Medical Group's current stock price of $21.39.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: A.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 29, which is 3 points higher than the healthcare sector average of 26. It passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 75.56% over the past year, overperforming other healthcare stocks by 138 percentage points.

What are the healthcare stocks with highest dividends?

Out of 69 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.91%, which is 9 percentage points higher than the healthcare sector average of 1.92%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.48%, which is 8 percentage points higher than the healthcare sector average of 1.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.6%, which is 4 percentage points higher than the healthcare sector average of 1.92%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and down -1.76% over the last week. Corcept Therapeutics was the among the top losers in the healthcare sector, dropping -50.42% yesterday.

Corcept Therapeutics shares are trading lower after the company announced it received a Complete Response Letter for Relacorilant from the FDA.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -51.94% in the past year. It has overperformed other stocks in the healthcare sector by 11 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 8.75% in the past year. It has overperformed other stocks in the healthcare sector by 71 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -13.77% in the past year. It has overperformed other stocks in the healthcare sector by 49 percentage points.

Are healthcare stocks a good buy now?

57.52% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 31.56% over the next year.

7.72% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.81% of healthcare stocks are rated B (Buy), 47.84% are rated C (Hold), 24.68% are rated D (Sell), and 7.95% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 62.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.